Dupixent and Weakness - a phase IV clinical study of FDA data
Weakness is found among people who take Dupixent, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Dupixent and have Weakness. It is created by eHealthMe based on reports of 70,472 people who have side effects when taking Dupixent from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
70,472 people reported to have side effects when taking Dupixent.
Among them, 379 people (0.54%) have Weakness.
What is Dupixent?
Dupixent has active ingredients of dupilumab. eHealthMe is studying from 70,512 Dupixent users for its effectiveness, alternative drugs and more.
What is Weakness?
Weakness is found to be associated with 5,051 drugs and 5,965 conditions by eHealthMe.
Number of Dupixent and Weakness reports submitted per year:
Time on Dupixent when people have Weakness *:
Gender of people who have Weakness when taking Dupixent*:
Age of people who have Weakness when taking Dupixent *:
Common drugs people take besides Dupixent *:
Common side effects people have besides Weakness *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Dupixent and have Weakness?Check whether Weakness is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Dupixent:
- Dupixent (70,512 reports)
Weakness treatments and more:
- Weakness (474,676 reports)
COVID vaccines that are related to Weakness:
- Weakness in Moderna COVID Vaccine
- Weakness in Pfizer BioNTech Covid Vaccine
- Weakness in Johnson and Johnson Covid Vaccine
How severe was Weakness and when was it recovered:
Expand to all the drugs that have ingredients of dupilumab:
Common drugs associated with Weakness:
All the drugs that are associated with Weakness:
- Weakness (5,051 drugs)
Common conditions associated with Weakness:
All the conditions that are associated with Weakness:
- Weakness (5,965 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on dupilumab (the active ingredients of Dupixent) and Dupixent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.